Erythropoietin or the “Blood Hormone”: Stimulates Red Blood Cell Production and Supports Optimal Body Function

The human body is a complex system, where hormones act as essential messengers, regulating vital functions and maintaining a crucial balance. Produced by endocrine glands, these chemical messengers reach target tissues through the bloodstream, triggering specific reactions. Each hormone plays a well-defined role in the body’s intricate orchestra, and erythropoietin is one of them. This hormone has a vital role in the production of red blood cells – the cells responsible for transporting oxygen to all body tissues, essential for the function of cells and organs.

Learn all about erythropoietin and how it helps the body, including its effects on athletic performance and how it is perceived in the sports world.

Erythropoietin: What it is and its role in the body?

From adrenaline, which prepares us to react quickly to emergencies, to insulin, which regulates blood sugar levels, each hormone plays a well-defined role in the body, including *erythropoietin*.

What is erythropoietin?

Erythropoietin (EPO) is a glycoprotein hormone, primarily produced by the kidneys and to a lesser extent by the liver. It plays an essential role in regulating the production of red blood cells (erythrocytes) in the blood. This hormone stimulates erythropoiesis: the process of formation and maturation of erythrocytes (red blood cells) in the bone marrow.

The process of erythropoietin secretion in the kidneys

Erythropoietin is mainly secreted by specialized cells in the kidneys called peritubular interstitial cells or renal fibroblasts. These cells are responsible for monitoring oxygen levels in the blood, and erythropoietin production is adapted according to the body’s needs.

1. Peritubular interstitial cells in the kidneys act as sensors of blood oxygen levels. These sensors are highly sensitive to oxygen changes and respond promptly to hypoxia (low oxygen levels).
2. At the molecular level, there is a factor called *hypoxia-inducible transcription factor* (HIF). Under conditions of low oxygen, HIF is stabilized and activated, stimulating the synthesis of erythropoietin and its release into circulation. It is then transported through the blood to the bone marrow. Conversely, when oxygen levels are normal or high, HIF reduces erythropoietin production. There is, therefore, a negative feedback mechanism that maintains blood oxygen homeostasis.
3. Erythropoietin acts on hematopoietic stem cells in the bone marrow, stimulating their proliferation and differentiation into erythroblasts – the precursors of erythrocytes.
4. These precursors then mature into erythrocytes, i.e., red blood cells, which are released into the bloodstream and increase the body’s capacity to transport oxygen. In this way, normal oxygen levels are restored.

Erythropoietin: the role in red blood cell production

Stimulating red blood cell production is the most important role erythropoietin has in our body. The constant regulation of blood oxygen levels is essential for adequate oxygenation of all tissues and organs.

In situations of anemia, massive bleeding, high altitude (when atmospheric oxygen is lower), or lung diseases, blood oxygen levels decrease. Thus, EPO production is stimulated to increase the number of erythrocytes and, consequently, the oxygen transport capacity, compensating for its deficit.

This entire regulatory mechanism helps maintain an adequate balance between tissue oxygen needs and blood oxygen transport capacity. In this way, the proper functioning of the body is ensured.

Erythropoietin – structure and administration

Erythropoietin is a glycoprotein composed of an amino acid chain, to which carbohydrate chains (glycans) are attached. This complex structure allows it to bind to specific receptors on bone marrow cells and stimulate erythropoiesis.

Molecularly, human erythropoietin is made up of 165 amino acids, with a molecular weight of approximately 34 kDa (kilodaltons). The carbohydrate chains, which represent about 40% of the molecule’s total mass, are essential for its stability in circulation and its biological activity.

How is erythropoietin administered?

As medical treatment, erythropoietin is mainly used in anemia associated with chronic kidney disease, chemotherapy, or other conditions that lead to a decrease in red blood cell production. It is administered in injectable form: either subcutaneously or intravenously.

• Subcutaneous administration is the most common method of administering EPO, as it allows for gradual absorption of the drug. Subcutaneous injections are usually given in the abdomen, thighs, or arms. It is preferred in patients with chronic kidney disease and those who do not require emergency treatment, as it allows for smaller and less frequent doses.
• Intravenous administration is mainly used in patients undergoing dialysis or in situations where an immediate increase in red blood cell count is necessary. The effect is indeed faster than that obtained by subcutaneous administration, but the duration of action may be shorter. This method is preferred during dialysis sessions when vascular access is already available.

Liposomal Iron: role in hemoglobin production

Iron is an essential element in hemoglobin production. By increasing iron levels in the body, iron supplements support the production of hemoglobin and red blood cells, improving the efficiency of the EPO-regulated process. Liposomal Iron capsules at 25mg are a supplement with an impressive absorption capacity in the body, exceeding 99%. Erythropoietin stimulates erythropoiesis, but its effect depends on the presence of iron – an essential mineral for our body. Its absence means a tired body, lacking energy and vulnerable to external threats.

[cta_produs style=”style_1″ product=”305128″ image=”https://aronia-charlottenburg.com/wp-content/uploads/2024/11/1.2.-Eritropoietina-structura-Fier-Lipozomal-la-25-mg.jpg”]

Consequently, by improving iron absorption and supporting the erythropoiesis process, these capsules help prevent anemia and ensure healthy red blood cell production, essential for proper body oxygenation.

[cta_produs style=”style_2″ product=”305128″ image=”https://aronia-charlottenburg.com/wp-content/uploads/2024/11/12ERIT2.jpg”]

In addition, they contribute to strengthening the immune system and support brain, muscle, and thyroid health. As they do not contain lactose or gluten, they can also be consumed by vegans or those with restrictive diets.

Erythropoietin in sports

In some cases, erythropoietin is used illegally as a doping substance in sports. Given its oxygen transport-enhancing effect, it increases exercise capacity.

In sports such as cycling, running, cross-country skiing, or triathlon, endurance and the body’s ability to efficiently transport oxygen to the muscles are essential factors for performance. EPO can therefore have a direct impact on athletic performance in these cases.

Detecting EPO use is difficult, as the synthetic drug has a very similar structure to the hormone naturally present in the body. However, blood and urine tests can identify some differences between synthetic and natural erythropoietin, as well as the physiological effects of its use (such as increased hematocrit).

Health Risks

Abusive use of EPO can have serious health consequences, including:

1. Increased blood viscosity due to an excessive number of red blood cells can lead to clot formation (thrombosis), high blood pressure, strokes, and heart attacks;
2. In combination with dehydration or the use of diuretics, dangerous electrolyte imbalances can occur;
3. Without medical monitoring, pre-existing cardiovascular problems can worsen, or new problems may arise, such as high blood pressure or kidney dysfunction;
4. Deaths have also been reported among athletes who used EPO for doping, due to increased cardiovascular risks.

Erythropoietin plays an important role in sports medicine, especially for treating anemia or physiologically supporting performance. However, its use for doping purposes is dangerous. The benefits to athletic performance are accompanied by significant health risks and moral controversies, which has led to its strict prohibition in official sports competitions.

Erythropoietin deficiency: causes and remedies for low erythropoietin

Erythropoietin deficiency can lead to anemia. Also, an excess of EPO can mean an excessive number of erythrocytes, increasing the risk of clotting and cardiovascular complications.

Low erythropoietin: main causes

Decreased EPO levels can have various causes. The most common are related to kidney problems or other conditions affecting the production of this hormone.

Chronic Kidney Disease

The primary site of erythropoietin production is the kidneys, so chronic kidney conditions or kidney failure lead to reduced EPO production. This causes a decrease in red blood cell production, ultimately leading to renal anemia. Thus, these diseases are one of the most common causes of low erythropoietin.

Inflammation and Chronic Diseases

In chronic inflammatory diseases, such as rheumatoid arthritis, lupus, or other autoimmune conditions, there is a suppression of erythropoietin production, partly due to systemic inflammation.

Endocrine Deficiency

Certain hormonal conditions, such as hypothyroidism, pituitary insufficiency, or testosterone deficiency, can indirectly affect erythropoietin production and red blood cell formation.

Poisoning or certain medications

Some medications, such as immunosuppressants, certain antibiotics, or anticonvulsants, can affect kidney function or EPO production. Heavy metal poisoning (lead, mercury) can also affect erythropoietin production.

Low erythropoietin levels lead to anemia – a condition characterized by a low number of red blood cells in the blood. This translates into symptoms such as fatigue, weakness, paleness, and shortness of breath. Treatment for low erythropoietin production depends on the underlying cause and may include EPO-stimulating medications or blood transfusions to alleviate anemia.

Can erythropoietin deficiency be remedied?

Erythropoietin deficiency can be remedied in most cases, depending on its cause. The main approach consists of administering replacement therapy with synthetic erythropoietin or treating the underlying cause of EPO deficiency.

Ways to remedy erythropoietin deficiency

Recombinant (synthetic) erythropoietin therapy

The most common treatment method is the administration of synthetic erythropoietin (alpha or beta) or darbepoetin (long-acting). This therapy is mainly used in patients with chronic kidney disease who have low erythropoietin levels and develop anemia. The dose and frequency of administration vary according to the patient’s needs, and hemoglobin levels and response to treatment are closely monitored.

Treating the underlying cause

If EPO deficiency is caused by other conditions, treating those conditions may improve erythropoietin production. For example, in cases of chronic inflammatory or autoimmune diseases, controlling inflammation with medications (such as *corticosteroids* or *immunosuppressants*) can help normalize EPO levels.

Blood transfusions

In cases of severe anemia, if hemoglobin levels are very low and symptoms are pronounced, blood transfusions may be used. This is a short-term solution, usually used until the cause leading to erythropoietin deficiency is addressed.

Correcting nutritional deficiencies

If EPO deficiency is accompanied by other nutritional deficiencies (such as iron, vitamin B12, or folic acid deficiency), it is essential to correct them, as they influence optimal red blood cell formation.

Treatment with synthetic EPO must be carefully monitored to avoid overproduction of red blood cells, which can lead to high blood pressure and a higher risk of thrombosis (blood clots). The dose of synthetic EPO must be adjusted according to the patient’s response and hemoglobin levels to ensure adequate and safe correction of anemia.

Erythropoietin: normal values and influencing factors

Testing erythropoietin levels is necessary for diagnosing other conditions, especially those involving problems with red blood cell production or kidney function. Examples include anemia, polycythemia, kidney diseases, and chronic lung conditions.

The test for EPO levels is not routinely used to evaluate anemia or polycythemia. It is used when the cause of anemia or polycythemia is unclear or when there are suspicions of an erythropoietin production disorder.

Other tests (such as complete blood count, iron levels, vitamin B12, and folic acid) are generally performed before the EPO test to evaluate anemia.

Normal erythropoietin values

Normal erythropoietin (EPO) levels in the blood can vary depending on the laboratory performing the test, but they are generally between 2.6 and 18.5 mU/mL (*milli-international units per milliliter*).

Depending on the testing method and the patient’s condition, these values may vary slightly, so an accurate interpretation must be made by a doctor.

Factors influencing erythropoietin levels

Blood oxygen level

Erythropoietin is produced in response to hypoxia. A decrease in oxygen levels naturally leads to an increase in EPO secretion to stimulate red blood cell production. Hypoxia occurs especially in cases of bleeding, anemia, or exposure to high altitude.

Kidney function

The kidneys are the main organ responsible for erythropoietin production. Chronic kidney diseases or kidney failure lead to reduced EPO secretion and, consequently, anemia. Patients with kidney conditions generally have low EPO levels, leading to a reduced ability to form red blood cells.

Hematological diseases

Iron or B12 deficiency causes anemia. Massive blood loss has the same effect. These conditions stimulate erythropoietin production to compensate for the red blood cell deficit. Also, polycythemia vera is a condition in which the bone marrow produces an excess of red blood cells. This condition is associated with low EPO levels. The body thus tries to reduce the formation of new erythrocytes.

Chronic diseases and inflammation

Chronic inflammatory diseases, such as rheumatoid arthritis, lupus, chronic liver diseases, or cancer, can affect erythropoietin production. Chronic inflammation inhibits EPO secretion and can affect the response to this hormone. Also, anemias associated with chronic diseases may present normal or slightly elevated EPO levels, but which are insufficient to compensate for the anemia.

Certain medications and treatments

Chemotherapy and other treatments that affect the bone marrow can reduce red blood cell production and increase EPO levels in response to anemia. The same effect can be caused by the administration of medications, such as immunosuppressants.

Lifestyle and external factors

High altitude can lead to increased EPO levels. This happens because the rarefied air reduces the amount of available oxygen. This stimulates erythropoietin production to increase the number of red blood cells. Therefore, people living at high altitudes or athletes training in such conditions are at higher risk of facing this problem. Chronic smoking can also increase EPO levels. This occurs due to a decrease in the blood’s oxygen-carrying capacity, caused by inhaled carbon monoxide.

Hormonal status

Testosterone levels can indirectly stimulate erythropoietin production, increasing the capacity to produce red blood cells. At the same time, hormonal deficiencies (e.g., thyroid hormone deficiency) can affect the production of erythropoietin and the formation of erythrocytes.

If erythropoietin levels are abnormal, the interpretation of the results must be done by a doctor. They will take into account the patient’s complete clinical picture. They will also consider associated conditions.

In conclusion, the body’s balance is extremely delicate. Erythropoietin is an essential hormone for maintaining this balance. Its therapeutic use brings undeniable benefits to patients with anemia. It also helps in other conditions affecting the blood. However, its improper use in sports raises numerous issues. Understanding its role and its effects on human health and performance is important. This allows us to appreciate the complexity of how the body regulates its functions.

References:

https://www.medicalnewstoday.com/articles/erythropoietin

https://my.clevelandclinic.org/health/articles/14573-erythropoietin

https://www.hematology.org/about/history/50-years/erythropoietin

https://www.ncbi.nlm.nih.gov/books/NBK536997/

https://www.urmc.rochester.edu/encyclopedia/content.aspx?contenttypeid=167&contentid=erythropoietin_blood

Photo source: shutterstock.com